Skip to main content

BIMI International Medical Inc. Signs MoU to Acquire Bengbu Mali Maternity Hospital

Written by Customer Service on . Posted in Mergers And Acquisitions.

NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) — BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider, today announced that it has signed a Memorandum of Understanding (MoU) for the acquisition 100% interest of Bengbu Mali Maternity Hospital through BIMI’s common shares at the price of $3.00 per share.

Bengbu Mali Maternity Hospital is a professional obstetrics and gynecology hospital, which provides services to around 30,000 patients per year. The hospital was founded in 2015, with outpatient and inpatient buildings totaling 24 floors. The profit of the hospital was $218,708 (RMB140,0000) in 2019 and predicted to be $937,324 (RMB 600,0000) in 2022.

Bengbu Mali Maternity Hospital’s departments include internal medicine, obstetrics and gynecology, pediatrics, emergency medicine, and anesthesiology. Apart from traditional obstetrics and gynecology services, the hospital has personalized health services for women, including pre-pregnancy services, postpartum repair, and infant care. It also has programs in slimming shaping, repairing postpartum scars, and private reproductive health management.

Under the terms of the MoU, BIMI International Medical Inc. is to acquire 100% interest in Mali Maternity Hospital. Currently, BIMI plans to designate an independent third party for auditing and evaluating the hospital. Next, based on the qualified auditing and evaluating results, BIMI and the hospital plan to sign a Stock Purchase Agreement and BIMI would purchase the hospital. Finally, the hospital is to become a wholly-owned subsidiary of BIMI.  

“We are delighted that our hospital could join BIMI. We look forward to working with them and bringing our customized high-end maternity technology and services to help more patients,” said Ms. Zhenmei Jin, the majority shareholder of Mali Maternity Hospital.

“Mali Maternity Hospital is the first specialist hospital we are acquiring. With its advanced medical technology and equipment, obstetrics and gynecology could be a strength in our online-to-offline hospitals, and more patients could get help. We also plan to organize free online events for patients to communicate with doctors”, said Mr. Tiewei Song, Chief Executive Officer and President of BIMI International Medical Inc. “Entering into this MoU with Mali Maternity Hospital is a big step in expanding our online-to-offline network not only in terms of the geographic network but also of medical technology and talents network. After this acquisition closed, we will have six hospitals.”

About BIMI International Medical Inc.

BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and provider, offering a broad range of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.

Safe Harbor Statement

Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.

IR Contact:

Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BIMI@dgipl.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.